Team:UCSF/Project/Circuit/Data

<div id="description" style = "width:950px; height:230px" align="justify">

<font face="arial" size = "5"><b><center>Decision-Making Circuit: Promoter Design and Data</font></b> </center> <br>

<font face="arial" size = "4">

<FONT COLOR="#008000"><u>Promoter Selection and Testing: </FONT COLOR="#008000"></u><br>

In order to create synthetic circuit sensitive to differing levels of inducer, we first had to select promoters with favorable characteristics we could exploit to make them concentration-dependent -- namely a low basal level and a wide dynamic range. We chose four well-known promoters as possible candidates for our circuit: pLAC (lactose), pTet (tetracycline), pBAD (arabinose), and PprpB (proprionate). We constructed separate plasmids containing each of the promoters individually driving the expression of GFP, and using this system we characterized these promoters by measuring the GFP expression over time as a function of different inducer levels. We determined the basal level, highest induction level, and inducer range. Because of the low basal expression and the varying responsiveness at different inducer concentraions, we selected pLAC & pTET as the promoters for the synthetic circuit.<br></div>

<div id="description" style = "width:700px; height:100px; margin-left:180px" align="justify">

<font face="arial" size = "2">Dose-response curve for pLAC promoter induced with different amount of inducers (0, 0.1, 1, 10, 20, 40, 60, 80, 120 uM IPTG). Cells were grow to mid-log phase and then start induction. OD600 value and GFP fluorescence level of each sample were measured by plate reader after saturation. GFP fluorescence were corrected for OD600 value. The red line indicated Hill function fit of the dose-response curve and error bars indicate standard deviation calculated on the basis of technical replicates.</font>

<img style="margin-top:10px"; padding:0;" "width:400px"

<div id="description" style = "width:700px; height:100px" align="justify">

<font face="arial" size = "2">Dose-response curve for pTET promoter induced with different amount of inducers (0, 0.004, 0.01, 0.04, 0.06, 0.11 uM aTc). Cells were grow to mid-log phase and then start induction. OD600 value and GFP fluorescence level of each sample were measured by plate reader after saturation. GFP fluorescence were corrected for OD600 value. The red line indicated Hill function fit of the dose-response curve and error bars indicate standard deviation calculated on the basis of technical replicates.</font>

<div id="description" style = "width:950px; height:200px" align="justify">

<font face="arial" size = "4">

<FONT COLOR="#008000"><u>Altering Promoter Sensitivity: </FONT COLOR="#008000"></u><br>

<br>Our next goal after our promoter assays was to create engineered versions of our promoters responsive to high and low levels of inducer, either by modifying activation or repression of the specific promoter. Based on <a href="http://www.ncbi.nlm.nih.gov/pubmed/16432263">previous work</a>in the literature characterizing the pLAC promoter, we chose to change both the number and orientation of repressor binding sites in pLAC. To create our "low" inducer promoter, we shifted the O1 operator site further downstream of our promoter sequence and removed another operator site from pLAC to relieve repression. To create our "high" promoter, we took the "low" promoter and added the O3 operator site further upstream near the start of the promoter sequence. The O3 operator site will then form a loop with our O1 operator site, thus creating a physical barrier to prevent transcription, reducing the promoter activity at low levels of inducer. </font>

<br><font face="arial" size = "2">From <a href="http://www.ncbi.nlm.nih.gov/pubmed/16432263">Oehler <i>et al.</i>, 2006.</a> </center><br></div>

<div id="description" align="justify" style = "width:950px; height:150px">

<font face="arial" size = "4">

<br>Using a similar GFP reporter system as for the first promoter tests, we were able to show that our engineered pLAC promoters are now concentration sensors and can be used to create a circuit that responds differently to varying inducer levels. We plan to implement a similar strategy for the pTET promoter design to implement it in a parallel circuit.</center>

<br>

<br>

<font face="arial" size = "7">PROMOTER DATA</font>

<br><font face="arial" size = "5"><b><center>Decision-Making Circuit: Circuit Output</font></b> </center> <br>

<font face="arial" size = "4">

<br><br>Our proof-of-concept design is, at a low level of inducer, to express GFP simultaneously with a gRNA to repress RFP. When the inducer level increases, the "high" sensing promoter turns on expression of RFP and a gRNA to repress GFP, making a switch-like decision based on the input. We were able to construct an early design of the circuit in the pCDF plasmid that contains both fluorescent proteins and gRNAs. We initially put both components of the circuit under individual promoters, pLAC and pTET, as a control to test whether or not we could obtain expression of both products and repression from the gRNAs, both under individual induction and after switching inducers. Since this circuit relies on CRISPR repression, we had to also construct a plasmid (pACYC) containing the catalytically dead dCas9 protein as well as the Csy4 protein to cleave the RNA products (see Design page or Parts Registry for more information). We are in the final stages of cloning the dCas9 plasmid and we hope to test the circuit before the Jamboree.